ArticleBriefings in bioinformatics2024
Dual-channel hypergraph convolutional network for predicting herb-disease associations.
Article in Briefings in bioinformatics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed.
- A Review ofFoods (Basel, Switzerland) · 2026Review
- Metapath2vec and attention-driven heterogeneous graph learning for prioritizing TCM-derived small molecules in gastric cancer.Chinese medicine · 2026Article
- GHF-ACL: A novel contrastive learning framework with multi-order graph structures for herb-disease association prediction.PLoS computational biology · 2026Article
- Machine learning-guided Huanglian Jiedu decoction targets STING in periodontitis-induced Alzheimer's Disease.NPJ digital medicine · 2026Article
- MAMGN-HTI: A Graph Neural Network Model with Metapath and Attention Mechanisms for Hyperthyroidism Herb-Target Interaction Prediction.Bioengineering (Basel, Switzerland) · 2025Article
- The integration of machine learning into traditional Chinese medicine.Journal of pharmaceutical analysis · 2025Review
- Identifying novel therapeutic targets of natural compounds in traditional Chinese medicine herbs with hypergraph representation learning.Briefings in bioinformatics · 2025Article
- Inter-view contrastive learning and miRNA fusion for lncRNA-protein interaction prediction in heterogeneous graphs.Briefings in bioinformatics · 2025Article
- Herb-disease association prediction model based on network consistency projection.Scientific reports · 2025Article
- Drug discovery and mechanism prediction with explainable graph neural networks.Scientific reports · 2025Article
- TCMRGAT: Relational graph attention networks for predicting stroke treatment efficacy of traditional Chinese medicine prescriptions.Frontiers in pharmacology · 2025Article
- Exploring the role of topological descriptors to predict physicochemical properties of anti-HIV drugs by using supervised machine learning algorithms.BMC chemistry · 2024Article
- MvGraphDTA: multi-view-based graph deep model for drug-target affinity prediction by introducing the graphs and line graphs.BMC biology · 2024Article
- An improved data augmentation approach and its application in medical named entity recognition.BMC medical informatics and decision making · 2024Article
- Drug-target interaction prediction through fine-grained selection and bidirectional random walk methodology.Scientific reports · 2024Article
- Explainable drug repurposing via path based knowledge graph completion.Scientific reports · 2024Article
- Drug repurposing based on the DTD-GNN graph neural network: revealing the relationships among drugs, targets and diseases.BMC genomics · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Herbs applicability in disease treatment has been verified through experiences over thousands of years. The understanding of herb-disease associations (HDAs) is yet far from complete due to the complicated mechanism inherent in multi-target and multi-component (MTMC) botanical therapeutics. Most of the existing prediction models fail to incorporate the MTMC mechanism. To overcome this problem, we propose a novel dual-channel hypergraph convolutional network, namely HGHDA, for HDA prediction. Technically, HGHDA first adopts an autoencoder to project components and target protein onto a low-dimensional latent space so as to obtain their embeddings by preserving similarity characteristics in their original feature spaces. To model the high-order relations between herbs and their components, we design a channel in HGHDA to encode a hypergraph that describes the high-order patterns of herb-component relations via hypergraph convolution. The other channel in HGHDA is also established in the same way to model the high-order relations between diseases and target proteins. The embeddings of drugs and diseases are then aggregated through our dual-channel network to obtain the prediction results with a scoring function. To evaluate the performance of HGHDA, a series of extensive experiments have been conducted on two benchmark datasets, and the results demonstrate the superiority of HGHDA over the state-of-the-art algorithms proposed for HDA prediction. Besides, our case study on Chuan Xiong and Astragalus membranaceus is a strong indicator to verify the effectiveness of HGHDA, as seven and eight out of the top 10 diseases predicted by HGHDA for Chuan-Xiong and Astragalus-membranaceus, respectively, have been reported in literature.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.